Redhill Biopharma Inc.

NC · United States · Reporting entity ID 100000751811

Total reported 2019–2025

$5.52M

#674 of 2,960 reporting companies — 0% of all reported industry payments

$3.73M in general payments across 56,450 records, plus $1.78M in research funding across 298 records.

How it breaks down

General payments $3,734,596

Research funding $1,783,527

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.